DOCSLIB.ORG

TLR7 Induces Anergy in Human CD4+ T Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TLR7 Induces Anergy in Human CD4+ T Cells ARTICLES TLR7 induces anergy in human CD4+ T cells Margarita Dominguez-Villar1, Anne-Sophie Gautron1, Marine de Marcken1, Marla J Keller2 & David A Hafler1 The recognition of microbial patterns by Toll-like receptors (TLRs) is critical for activation of the innate immune system. Although TLRs are expressed by human CD4+ T cells, their function is not well understood. Here we found that engagement of TLR7 in CD4+ T cells induced intracellular calcium flux with activation of an anergic gene-expression program dependent on the transcription factor NFATc2, as well as unresponsiveness of T cells. As chronic infection with RNA viruses such as human immunodeficiency virus type 1 (HIV-1) induces profound dysfunction of CD4+ T cells, we investigated the role of TLR7-induced anergy in HIV-1 infection. Silencing of TLR7 markedly decreased the frequency of HIV-1-infected CD4+ T cells and restored the responsiveness of those HIV-1+ CD4+ T cells. Our results elucidate a previously unknown function for microbial pattern– recognition receptors in the downregulation of immune responses. Toll-like receptors (TLRs) represent the major pathway by which immunodeficiency virus type 1 (HIV-1), the immune responses medi- microorganisms interact with host cells. They are a family of highly ated by CD4+ helper T cells and CD8+ cytotoxic T cells determine the out- conserved pattern-recognition receptors that recognize distinct come of the infection, with chronic infections being correlated with late, pathogen-associated molecular patterns that are conserved in specific transient or narrowly focused responses by CD4+ or CD8+ T cells9–11. classes of microorganisms1. The human TLR family consists of at least Several studies have demonstrated impairment in the activation and/or ten members that can be classified into two different groups on the basis function of T cells during infection with HIV-1. Specifically, CD4+ of their cellular location. Intracellular TLRs (TLR3, TLR7, TLR8 and T cells from patients chronically infected with HIV-1 display an anergic TLR9) recognize nucleic acids; TLR7 and TLR8 recognize single- phenotype with defects in proliferation and the secretion of interleukin stranded RNA2,3, whereas TLR3 and TLR9 are receptors for double- 2 (IL-2) and interferon-γ (IFN–γ). The mechanisms by which RNA stranded RNA and double-stranded DNA, respectively. In contrast, viruses impair T cell function are not well understood. Nature America, Inc. All rights reserved. America, Inc. Nature cell surface TLRs (TLR1, TLR2, TLR4, TLR5 and TLR6) recognize Here we describe a previously unrecognized pathway of TLR- 5 various components of bacteria1. In mice, although TLR7 and TLR8 are mediated negative regulation of both the activation and the cytokine expressed at low levels in CD4+ T cells, there are species-specific dif- production of CD4+ T cells. Engaging TLR7 expressed on CD4+ © 201 ferences in the recognition of ligands3 as well as in their functionality. T cells resulted in complete anergy by inducing intracellular calcium Specifically, mouse TLR7 and human TLR8 mediate species-specific flux, with activation of an anergic gene-expression program depend- recognition of GU-rich single-stranded RNA. It has been suggested ent on the transcription factor NFATc2 and with subsequent T cell npg that in contrast to its human TLR counterpart, mouse TLR8 is not unresponsiveness that was reversed by knockdown of TLR7 with functional and TLR7 is the only TLR that recognizes single-stranded short hairpin RNA (shRNA). In studies of the potential physiological RNA4. The expression and signaling pathways triggered by stimula- relevance of these findings, we found that knockdown of TLR7 via tion of TLRs have been described in antigen-presenting cells (APCs) shRNA decreased the frequency of HIV-1-infected CD4+ T cells in a process that leads to the activation of APCs with the secretion in vitro and restored the responsiveness of those HIV-1+ CD4+ of inflammatory and antiviral cytokines1,5. Although TLR expression T cells in vitro. Our results elucidate a previously unknown function has been studied mainly in APCs, several reports have described the for microbial pattern–recognition receptors in the downregulation expression of TLRs on lymphocytes6, and specifically on CD4+ T cells. of immune responses, inducing anergy by increasing intracellular As with APCs, such studies indicate that the engagement of TLRs acts calcium concentrations and interfering with secondary costimulation as a positive costimulatory signal that increases the secretion of proin- signals in the presence of signaling via TLRs7. flammatory cytokines, proliferation and cell survival7,8. While TLRs are central to the early host immune response to acute RESULTS viral infection, more-chronic infectious diseases are characterized by Inhibition of the activation of CD4+ T cells by TLR7 the inability of the host immune system to mount a strong, long-lasting While investigating a potential costimulatory role for TLRs in CD4+ response to the infectious agent. In particular, it has been shown that T cells, we observed that the entry of CD4+ T cells into the cell cycle during infection with RNA viruses such as hepatitis C virus and human after crosslinking of the T cell antigen receptor (TCR) with antibody 1Department of Neurology and Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. 2Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA. Correspondence should be addressed to M.D.-V. ([email protected]) or D.A.H. ([email protected]). Received 18 June; accepted 20 October; published online 17 November 2014; doi:10.1038/ni.3036 118 VOLUME 16 NUMBER 1 JANUARY 2015 NATURE IMMUNOLOGY ARTICLES Nature America, Inc. All rights reserved. America, Inc. Nature 5 © 201 npg Figure 1 TLR7 signaling inhibits the proliferation and cytokine secretion of CD4+ T cells. (a) Proliferation of CD4+ T cells labeled with the cytosolic dye CFSE and stimulated for 3 d with various concentrations (above plots) of imiquimod (IMQ). Numbers above bracketed lines indicate percent viable proliferating CD4+ T cells. (b) Frequency of viable proliferating CD4+ T cells stimulated for 3 d with various concentrations (horizontal axis) of imiquimod. (c) ELISA of cytokine secretion by CD4+ T cells stimulated for 3 d with various concentrations of imiquimod. (d) Intracellular staining of IFN-γ and IL-2 (top) and of IL-17 and IL-4 (bottom) in CD4+ T cells stimulated for 4 d with various concentrations of imiquimod and then stimulated for with 4 h PMA and ionomycin. Numbers in quadrants indicate percent cells in each throughout. (e) Frequency of cytokine-producing CD4+ T cells (as in d). (f) Expression of CD25 (left), CD69 (middle) and CD137 (right) on CD4+ T cells stimulated with anti-CD3 and anti-CD28 in the presence (α-CD3 and α-CD28 + IMQ) or absence (α-CD3 and α-CD28) of imiquimod, and of cells stained with isotype-matched control antibody (Isotype). MFI, mean fluorescence intensity. *P < 0.05, **P < 0.005 and ***P < 0.0005 (paired t-test). Data are representative of eight (a–d) or six (e,f) independent experiments with one donor in each (mean and s.e.m. in b,c,e,f). to the invariant signaling protein CD3 (anti-CD3) and crosslinking of of up to 15 µg/ml of imiquimod but found no effect on cell viability the coreceptor CD28 with anti-CD28 was blocked by coengagement (data not shown). The diminished proliferation correlated with less of TLR7 (Fig. 1a,b and Supplementary Fig. 1a,b). Treatment with the secretion of the cytokines IFN-γ, IL-17, IL-2 and IL-4, as measured by synthetic TLR7 agonist imiquimod resulted in considerably less pro- enzyme-linked immunosorbent assay (ELISA), at day 3 after stimu- liferation of CD4+ T cells than that of vehicle-treated control cells, as lation (Fig. 1c). We confirmed the diminished cytokine secretion at well as less secretion of IFN-γ and IL-17, in a dose-dependent fashion the single-cell level, as the frequency of cytokine-producing cells was (Fig. 1c–e and Supplementary Fig. 1c,d). We observed this inhibitory also diminished in a dose-dependent manner with increasing doses of effect as soon as 12 h after activation, with much less induction of imiquimod in culture (Fig. 1d,e). Furthermore, stimulation of CD4+ the expression of IL2, IFNG and IL4 after treatment with imiquimod T cells in the presence of imiquimod inhibited the expression of (Supplementary Fig. 1e). We assessed the effect of concentrations activation markers such as CD25, CD69 and CD137, measured 48 h NATURE IMMUNOLOGY VOLUME 16 NUMBER 1 JANUARY 2015 119 ARTICLES a b Veh e Veh f GDQ IMQ 100 Veh GDQ Lox CL264 80 Lox 4 150 + 80 150 + CL264 60 ** ) 3 60 100 ml 100 / ng 40 70.9 8.3 9.1 55.3 40 2 γ ( 50 T cells (%) 50 20 IL-2 (U/ml) T cells (%) *** Proliferating CD4 Cells *** IFN- 2 3 4 5 20 1 0 10 10 10 10 *** *** Proliferating CD4 0 0 0.1 0.25 0.5 1 2.5 CFSE 0 0 0 NT TLR7(3) NT TLR7(3) ssRNA40 (µg/ml) Veh 150 4 1,000 2.0 400 8 c GDQ d NT g TLR7(3) * Lox 2.0 3 750 1.5 300 ) 6 ) CL264 ml 100 / * ml / 1.5 200 ng 4 ng 2 500 1.0 γ ( ** γ ( IL-2 (pg/ml) 100 IFN- 2 IL-2 (U/ml) 1.0 50 IL-4 (pg/ml) IL-17 (ng/ml) IFN- * *** 1 ** 250 0.5 mRNA (AU) *** * 0 0 *** * * * 0.5 0 0.1 0.25 0.5 1 2.5 0 0.1 0.25 0.5 1 2.5 * * TLR7 0 0 0 0 *** ssRNA40 (µg/ml) ssRNA40 (µg/ml) 0 1,000 4 NT TLR7(3) 800 Figure 2 The inhibitory effect of imiquimod 3 150 Isotype Isotype * * is TLR7 specific.
Load more

Recommended publications
  • RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
    RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Human Toll-Like Receptor Signaling Pathway Cat. no. 330231 PAHS-018ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Human Toll-Like Receptor (TLR) Signaling Pathway RT² Profiler PCR Array profiles the expression of 84 genes central to TLR-mediated signal transduction and innate immunity. The TLR family of pattern recognition receptors (PRRs) detects a wide range of bacteria, viruses, fungi and parasites via pathogen-associated molecular patterns (PAMPs). Each receptor binds to specific ligands, initiates a tailored innate immune response to the specific class of pathogen, and activates the adaptive immune response.
    [Show full text]
  • Bacterial Interactions with Cells of the Intestinal Mucosa: Toll- 1182 Like Receptors and Nod2
    Recent advances in basic science BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL- 1182 LIKE RECEPTORS AND NOD2 ECario Gut: first published as on 11 July 2005. Downloaded from Gut 2005;54:1182–1193. doi: 10.1136/gut.2004.062794 SUMMARY Toll-like receptors (TLR) and NOD2 are emerging as key mediators of innate host defence in the intestinal mucosa, crucially involved in maintaining mucosal as well as commensal homeostasis. Recent observations suggest new (patho-) physiological mechanisms of how functional versus dysfunctional TLRx/NOD2 pathways may oppose or favour inflammatory bowel disease (IBD). In Published online first 19 April 2005 health, TLRx signalling protects the intestinal epithelial barrier and confers commensal tolerance whereas NOD2 signalling exerts antimicrobial activity and prevents pathogenic invasion. In disease, aberrant TLRx and/or NOD2 signalling may stimulate diverse inflammatory responses leading to acute and chronic intestinal inflammation with many different clinical phenotypes. c INTRODUCTION The intestinal mucosa must rapidly recognise detrimental pathogenic threats to the lumen to initiate controlled immune responses but maintain hyporesponsiveness to omnipresent harmless commensals. Charles Janeway Jr first suggested that so-called pattern recognition receptors (PRRs) may play an essential role in allowing innate immune cells to discriminate between ‘‘self’’ http://gut.bmj.com/ and microbial ‘‘non-self’’ based on the recognition of broadly conserved molecular patterns.1 Toll- like receptors (TLRs) which comprise a class of transmembrane PRRs play a key role in microbial recognition, induction of antimicrobial genes, and the control of adaptive immune responses. NODs (NOD1 and NOD2) are a structurally distinct family of intracellular PRRs which presumably in the context of microbial invasion subserve similar functions (fig 1).
    [Show full text]
  • Sex and Suicide: the Curious Case of Toll-Like Receptors
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications in the Biological Sciences Papers in the Biological Sciences 3-23-2020 Sex and suicide: The curious case of Toll-like receptors Paulo A. Navarro-Costa Instituto Gulbenkian de Ciência & Universidade de Lisboa, [email protected] Antoine Molaro Fred Hutchinson Cancer Research Center Chandra S. Misra Instituto Gulbenkian de Ciência & Instituto de Tecnologia Quımica e Biologica Colin D. Meiklejohn University of Nebraska-Lincoln, [email protected] Peter J. Ellis University of Kent, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/bioscifacpub Part of the Biology Commons Navarro-Costa, Paulo A.; Molaro, Antoine; Misra, Chandra S.; Meiklejohn, Colin D.; and Ellis, Peter J., "Sex and suicide: The curious case of Toll-like receptors" (2020). Faculty Publications in the Biological Sciences. 772. https://digitalcommons.unl.edu/bioscifacpub/772 This Article is brought to you for free and open access by the Papers in the Biological Sciences at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in the Biological Sciences by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. PLOS BIOLOGY UNSOLVED MYSTERY Sex and suicide: The curious case of Toll-like receptors 1,2 3 1,4 Paulo A. Navarro-CostaID , Antoine MolaroID , Chandra S. MisraID , Colin 5 6 D. MeiklejohnID , Peter J. EllisID * 1 Instituto Gulbenkian de Ciência, Oeiras,
    [Show full text]
  • TLR7-Dependent Recognition of Viral RNA Cutting Edge
    Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA Jennifer P. Wang, Damon R. Asher, Melvin Chan, Evelyn A. Kurt-Jones and Robert W. Finberg This information is current as of September 24, 2021. J Immunol 2007; 178:3363-3367; ; doi: 10.4049/jimmunol.178.6.3363 http://www.jimmunol.org/content/178/6/3363 Downloaded from References This article cites 29 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/178/6/3363.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 24, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. THE JOURNAL OF IMMUNOLOGY CUTTING EDGE Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA1 Jennifer P. Wang,2 Damon R. Asher, Melvin Chan, Evelyn A. Kurt-Jones, and Robert W. Finberg TLR7 recognizes the genome of ssRNA viruses such as Cox- “atypical” measles, dengue hemorrhagic fever, and enhanced sackievirus B.
    [Show full text]
  • TLR7 Trafficking and Signaling in B Cells Is Regulated by the MHCII-Associated Invariant Chain
    © 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs236711. doi:10.1242/jcs.236711 RESEARCH ARTICLE SPECIAL ISSUE: CELL BIOLOGY OF THE IMMUNE SYSTEM TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain Mira Tohme1, Lucie Maisonneuve2,3, Karim Achour4, Michaël Dussiot5, Sophia Maschalidi6 and Bénédicte Manoury2,3,* ABSTRACT respectively. The localization, traffic and folding of intracellular Toll-like receptor 7 (TLR7) is an endosomal receptor that recognizes TLRs are regulated by the endoplasmic reticulum (ER)-resident single-stranded RNA from viruses. Its trafficking and activation is protein UNC93B1 (Tabeta et al., 2006; Brinkmann et al., 2007; regulated by the endoplasmic reticulum (ER) chaperone UNC93B1 Pelka et al., 2018; Majer et al., 2019). UNC93B1 binds directly to and lysosomal proteases. UNC93B1 also modulates major the transmembrane region of TLR3, TLR7, TLR8 and TLR9 in the histocompatibility complex class II (MHCII) antigen presentation, ER and transports them to endocytic compartments upon and deficiency in MHCII protein diminishes TLR9 signaling. These stimulation (Kim et al., 2008). In dendritic cells (DCs) purified results indicate a link between proteins that regulate both innate and from mice expressing a point mutation in UNC93B1 (3d), adaptive responses. Here, we report that TLR7 resides in lysosomes intracellular TLRs are retained in the ER, preventing DCs from and interacts with the MHCII-chaperone molecule, the invariant chain secreting cytokines upon engagement of TLR3, TLR7 and TLR9 (Ii) or CD74, in B cells. In the absence of CD74, TLR7 displays both (Tabeta et al., 2006). However, in B cells, even though UNC93B1 is ER and lysosomal localization, leading to an increase in pro- still required for intracellular TLR signaling, TLR9 seems, at the inflammatory cytokine production.
    [Show full text]
  • Recognition of Lipopolysaccharide Pattern by TLR4 Complexes
    OPEN Experimental & Molecular Medicine (2013) 45, e66; doi:10.1038/emm.2013.97 & 2013 KSBMB. All rights reserved 2092-6413/13 www.nature.com/emm REVIEW Recognition of lipopolysaccharide pattern by TLR4 complexes Beom Seok Park1 and Jie-Oh Lee2 Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria. Minute amounts of LPS released from infecting pathogens can initiate potent innate immune responses that prime the immune system against further infection. However, when the LPS response is not properly controlled it can lead to fatal septic shock syndrome. The common structural pattern of LPS in diverse bacterial species is recognized by a cascade of LPS receptors and accessory proteins, LPS binding protein (LBP), CD14 and the Toll-like receptor4 (TLR4)–MD-2 complex. The structures of these proteins account for how our immune system differentiates LPS molecules from structurally similar host molecules. They also provide insights useful for discovery of anti-sepsis drugs. In this review, we summarize these structures and describe the structural basis of LPS recognition by LPS receptors and accessory proteins. Experimental & Molecular Medicine (2013) 45, e66; doi:10.1038/emm.2013.97; published online 6 December 2013 Keywords: lipopolysaccharide (LPS); Toll-like receptor 4 (TLR4); MD-2; CD14; LBP INTRODUCTION the cell surface by a glycosylphosphatidylinositol anchor. CD14 In the initial phase of infection, the innate immune system splits LPS aggregates into monomeric molecules and presents generates a rapid inflammatory response that blocks the them to the TLR4–MD-2 complex. Aggregation of the TLR4– growth and dissemination of the infectious agent.
    [Show full text]
  • TLR8 Differences Between Human TLR7 and Synthetic TLR Agonists
    Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 Keith B. Gorden, Kevin S. Gorski, Sheila J. Gibson, Ross M. Kedl, William C. Kieper, Xiaohong Qiu, Mark A. Tomai, This information is current as Sefik S. Alkan and John P. Vasilakos of September 29, 2021. J Immunol 2005; 174:1259-1268; ; doi: 10.4049/jimmunol.174.3.1259 http://www.jimmunol.org/content/174/3/1259 Downloaded from References This article cites 36 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/174/3/1259.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 Keith B. Gorden, Kevin S. Gorski, Sheila J. Gibson, Ross M. Kedl,1 William C.
    [Show full text]
  • New Application of Anti-TLR Monoclonal Antibodies: Detection, Inhibition and Protection Ryutaro Fukui1*, Yusuke Murakami1,2 and Kensuke Miyake1,3*
    Fukui et al. Inflammation and Regeneration (2018) 38:11 Inflammation and Regeneration https://doi.org/10.1186/s41232-018-0068-7 REVIEW Open Access New application of anti-TLR monoclonal antibodies: detection, inhibition and protection Ryutaro Fukui1*, Yusuke Murakami1,2 and Kensuke Miyake1,3* Abstract Monoclonal antibody (mAb) is an essential tool for the analysis in various fields of biology. In the field of innate immunology, mAbs have been established and used for the study of Toll-like receptors (TLRs), a family of pathogen sensors that induces cytokine production and activate immune responses. TLRs play the role as a frontline of protection against pathogens, whereas excessive activation of TLRs has been implicated in a variety of infectious diseases and inflammatory diseases. For example, TLR7 and TLR9 sense not only pathogen-derived nucleic acids, but also self-derived nucleic acids in noninfectious inflammatory diseases such as systemic lupus erythematosus (SLE) or hepatitis. Consequently, it is important to clarify the molecular mechanisms of TLRs for therapeutic intervention in these diseases. For analysis of the molecular mechanisms of TLRs, mAbs to nucleic acid-sensing TLRs were developed recently. These mAbs revealed that TLR7 and TLR9 are localized also in the plasma membrane, while TLR7 and TLR9 were thought to be localized in endosomes and lysosomes. Among these mAbs, antagonistic mAbs to TLR7 or TLR9 are able to inhibit in vitro responses to synthetic ligands. Furthermore, antagonistic mAbs mitigate inflammatory disorders caused by TLR7 or TLR9 in mice. These results suggest that antagonistic mAbs to nucleic acid-sensing TLRs are a promising tool for therapeutic intervention in inflammatory disorders caused by excessive activation of nucleic acid-sensing TLRs.
    [Show full text]
  • TLR8 on Dendritic Cells and TLR9 on B Cells Restrain TLR7-Mediated Spontaneous Autoimmunity in C57BL/6 Mice
    TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice Benoit Desnuesa,b,c,1, Amanda Beatriz Macedoa,b,c,1, Annie Roussel-Quevala,b,c, Johnny Bonnardela,b,c, Sandrine Henria,b,c, Olivier Demariaa,b,c,2, and Lena Alexopouloua,b,c,3 aCentre d’Immunologie de Marseille-Luminy, Aix-Marseille University UM 2, 13288 Marseille, France; bInstitut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1104, 13288 Marseille, France; and cCentre National de la Recherche Scientifique, Unité Mixte de Recherche 7280, 13288 Marseille, France Edited* by Richard A. Flavell, Yale School of Medicine, Howard Hughes Medical Institute, New Haven, CT, and approved December 18, 2013 (received for review August 5, 2013) Systemic lupus erythematosus (SLE) is a complex autoimmune endosomal localization isolate TLR3, TLR7, TLR8, and disease with diverse clinical presentations characterized by the TLR9 away from self-nucleic acids in the extracellular space, still presence of autoantibodies to nuclear components. Toll-like re- self-RNA or -DNA can become a potent trigger of cell activation ceptor (TLR)7, TLR8, and TLR9 sense microbial or endogenous nucleic when transported into TLR-containing endosomes, and such acids and are implicated in the development of SLE. In mice TLR7- recognition can result in sterile inflammation and autoimmunity, deficiency ameliorates SLE, but TLR8- or TLR9-deficiency exacerbates including SLE (4, 15, 16). The connection of the endosomal the disease because of increased TLR7 response. Thus, both TLR8 TLRs with SLE originates mainly from mouse models, where and TLR9 control TLR7 function, but whether TLR8 and TLR9 act in TLR7 signaling seems to play a central role.
    [Show full text]
  • TLR3 Sensing of Viral Infection F
    The Open Infectious Diseases Journal, 2010, 4, 1-10 1 Open Access TLR3 Sensing of Viral Infection F. Dunlevy, N.G. McElvaney and C.M. Greene* Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland Abstract: Viral infection is detected by the innate immune system which mounts a rapid semi-selective defence involving inflammation and production of type 1 interferons. Several sensors, both cell surface and intracellular, exist to detect different types of viral motifs. Double-stranded RNA viruses and dsRNA replication intermediates are detected by toll- like receptor 3 (TLR3) as well as by retinoid-inducible gene 1 (RIG-I) like receptors. Binding of dsRNA or its synthetic analogue poly I:C to TLR3 recruits the adaptor protein TRIF and stimulates distinct pathways leading to activation of interferon regulatory factor (IRF) and NF-B. Here, we review the signalling cascades initiated by TLR3 and the modulation of these pathways. Keywords: TLR3, virus, dsRNA, signalling, type 1 interferons, NF-B. TLR3: SENSING OF VIRAL INFECTION TLR3 LIGANDS Human cells are equipped with a range of pattern- The ligand for TLR3 was identified as dsRNA relatively recognition receptors (PRRs) which recognise microbial recently in 2001 [1, 6]. Eight families of dsRNA viruses pathogen-associated molecular patterns (PAMPs), and mount exist including the rotaviruses which are implicated in infant innate immune responses following infection. Anti-viral mortality [7]. A further source of dsRNA is derived from the sensors can be broadly classified into two groups; toll-like replication of other RNA and DNA viruses which produce receptor family members and retinoid-inducible gene 1 dsRNA as a by-product of replication [8].
    [Show full text]
  • BCR/TLR7-Dependent Responses Autoreactive B Cells Constrains Cell-Intrinsic Expression of TLR9 In
    Cell-Intrinsic Expression of TLR9 in Autoreactive B Cells Constrains BCR/TLR7-Dependent Responses This information is current as Kerstin Nündel, Nathaniel M. Green, Arthur L. Shaffer, of September 24, 2021. Krishna L. Moody, Patricia Busto, Dan Eilat, Kensuke Miyake, Michael A. Oropallo, Michael P. Cancro and Ann Marshak-Rothstein J Immunol 2015; 194:2504-2512; Prepublished online 13 February 2015; Downloaded from doi: 10.4049/jimmunol.1402425 http://www.jimmunol.org/content/194/6/2504 Supplementary http://www.jimmunol.org/content/suppl/2015/02/13/jimmunol.140242 http://www.jimmunol.org/ Material 5.DCSupplemental References This article cites 49 articles, 26 of which you can access for free at: http://www.jimmunol.org/content/194/6/2504.full#ref-list-1 Why The JI? Submit online. by guest on September 24, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Cell-Intrinsic Expression of TLR9 in Autoreactive B Cells Constrains BCR/TLR7-Dependent Responses Kerstin Nundel,*€ ,1 Nathaniel M.
    [Show full text]
  • The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases
    REVIEW ARTICLE The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Laszlo Romics, Jr, MD, PhD, MRCS; Gyongyi Szabo, MD, PhD; John Calvin Coffey, PhD, AFRCSI; Jiang Huai Wang, PhD; Henry Paul Redmond, MCh, FRCSI Objective: To outline the emerging significance of Toll- of pathogens renders them a key figure in the activation like receptor (TLR) signaling pathways in surgical dis- of both innate and adaptive immune responses during eases. sepsis. However, emerging evidence points to fundamen- tally important roles in ulcerative colitis, Crohn dis- Data Sources: A systematic review of the literature was ease, and Helicobacter pylori infection in the gastrointes- undertaken by searching the MEDLINE database for the tinal tract and in the development of atherosclerotic period 1966 to 2005 without language restriction. plaques in the cardiovascular system. Furthermore, re- cent studies suggest that the regulation of the TLR path- Study Selection: Original or review articles that de- way fulfills a central role in anticancer immunotherapy scribed experimental data on the activation of TLR sig- and in organ rejection after transplantation. naling pathways in surgically relevant diseases were se- lected for inclusion in this review. Conclusion: Given the clinical significance of TLR path- ways, the targeting of individual molecular components Data Extraction: Data were obtained from peer- is likely to offer a broad range of future therapeutic mo- reviewed articles and references. dalities. Data Synthesis: The role of TLRs in the recognition Arch Surg. 2006;141:595-601 OLL-LIKE RECEPTORS (TLRS) TLR5 is responsible for bacterial flagellin belong to the pattern rec- recognition. TLR9 is important in the rec- ognition receptor super- ognition of unmethylated CpG DNA de- family that recognizes dis- rived from bacteria.
    [Show full text]